An observational study in Obstructive Sleep Apnea, Sleep Disorder and Well-Being, Psychological, sponsored by Istituto Auxologico Italiano. Recruiting at 1 site in Italy. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-09-09.
Sponsored by Istituto Auxologico Italiano · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Sleep Apnea, Obstructive with a site in Italy — 9 open to participants now, 10 under way, none of them phase 3. Sleep Apnea, Obstructive · Italy.
Among the 29 studies in Sleep Apnea, Obstructive with a site in Italy, this one is the 8th largest by planned enrollment of the 10 observational ones that give a count, is one of 2 that started in 2024, is one of 10 observational ones, and was the 20th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →9 of the 29 studies in Sleep Apnea, Obstructive with a site in Italy are open now. Recruiting first, the newest first:
Wissenschaftliches Institut Bethanien e.V · Sites in Italy, Belgium, France and 8 more countries
Ages 40+
Fondazione Don Carlo Gnocchi ETS · Sites in Italy
Ages 18+
Fondazione Don Carlo Gnocchi Onlus · Sites in Italy
Ages 18+
IRCCS San Raffaele · Sites in Italy
Ages 18+
Danderyd Hospital · Sites in Italy, Sweden
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 20 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 4 4
First in 2007; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 65 is below the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 45 across the 19 interventional studies, 70 across the 10 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 29 have an industry lead sponsor. The 10 most frequent:
Istituto Auxologico Italiano is the lead sponsor of 204 studies on the registry; 70 are open to participants now.
Istituto Auxologico Italiano has 6 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 29 studies in Sleep Apnea, Obstructive with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This observational study aims to evaluate multiple dimensions of health in patients with Obstructive Sleep Apnea Syndrome (OSAS), before and after three weeks of ventilotherapy.
Specifically, the study aims to identify pre- vs post-treatment differences in the following domains:
Thus, patients will complete the following evaluations before (T0) and after (T1) ventilotherapy:
Obstructive Sleep Apnea Syndrome is associated with cognitive difficulties, low psychosocial wellbeing and quality of life; however, the possible beneficial contribution of ventilotherapy on these dimensions is not completely clear. Ventilotherapy restores brain oxygenation and improve rest, possibly increasing cognitive performances, psychosocial health and quality of life. Multidisciplinary approaches to the treatment of OSAS are rare, although recommended. Solid proof of OSAS comorbidities may encourage clinicians to adopt a holistic perspective of care, leading to better rehabilitative outcomes. Also, evidence of the beneficial effects of ventilotherapy could increase patients' compliance to ventilotherapy, which is generally low.
The study aims to evaluate multiple dimensions of patient's health before and after three weeks of ventilotherapy, focusing on the cognitive performance, the blood expression of biomarkers related to neurodegeneration, and individual's psychosocial wellbeing.
Overall, it is expected improved cognitive performances and psychosocial wellbeing after ventilotherapy. Also, a reduction in the blood expression of biomarkers related to neurodegeneration (if found before the treatment) is hypothesized, although the limited research in this field requires cautious predictions.
Comprehensive evidence about OSAS comorbidity, beyond breath and sleep difficulties, is mandatory to design innovative multidisciplinary rehabilitative approaches in line with a holistic perspective of care. Effective multidisciplinary approaches are considered the gold standard in medical care, leading to better treatment outcomes and higher patients' satisfaction.
Beyond the clear ethical implication of providing higher quality of treatment, multidisciplinary interventions also imply a shared responsibility of treatment, preventing from clinical misjudgments and professionals' burnout.
Individual affected by OSAS
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Breathing support device during sleeping
Also known as: CPAP
Overall cognitive functioning
Montreal Cognitive Assessment MoCA (score range: 0-30; higher scores indicate higher cognitive functioning)
Time frame: baseline and after 3 weeks
Selective attention
Multiple Features Target Cancellation (MFTC) test (accuracy score range from 0 to 1; higher score suggest better performance)
Time frame: baseline and after 3 weeks
Memory and learning
Selective Reminding Test - SRT: three scores are provided. 1) long term memory storage capacity (0-72), learning (0-72), delayed recall (0-12). Higher scores indicate better performance.
Time frame: baseline and after 3 weeks
Visuo-spatial abilities
Rey Figure - copy: test score range from 0 to 36, higher scores indicate better performance
Time frame: baseline and after 3 weeks
Inhibition
Stroop Test: higher time scores and error scores indicate worst inhibitory control
Time frame: baseline and after 3 weeks
Planning
Tower of London - ToL: higher time score ( 0-36) and accuracy score (0-36) indicate better performance
Time frame: baseline and after 3 weeks
Decision making
Balloon Analog Risk Task - BART (test score)
Time frame: baseline and after 3 weeks
biomarkers of neurodegeneration
blood concentration (pg/ml)
Time frame: baseline and after 3 weeks
psychosocial wellbeing and satisfaction
Psychological General Well-Being Index (i.e., test scores)
Time frame: baseline and after 3 weeks
Quality of life (perceived psycho-physical and socio-economic wellbeing and satisfaction)
Quality of Life Scale: 16-items self-report scored from 1 - terrible to 7 - delighted (score range 16-112); higher score indicate higher wellbeing and satisfaction.
Time frame: baseline and after 3 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Jun 2026, 28 months after the start.
Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 28 months is close to that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituto Auxologico Italiano →